Ouellette, Lisa Larrimore; Sampat, Bhaven N. - National Bureau of Economic Research - 2024
scope, march-in rights can be exercised only on patents that result from federally funded research, and they can enable … generic entry only if all patents on a drug were public-sector patents. In this paper, we examine the feasibility of using … march-in rights to lower pharmaceutical prices by examining patents on drugs approved by the U.S. Food and Drug …